{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:58:37Z","timestamp":1791575917873,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular Endothelial Growth Factors (VEGFs) are promising molecules for the treatment of ischemic diseases by pro-angiogenic therapy. Snake venom VEGFs are a novel subgroup with unique receptor binding profiles and as such are potential new therapeutic agents. We determined the ligand-receptor interactions, gene regulation and angiogenic properties of <jats:italic>Vipera ammodytes<\/jats:italic> venom VEGF, Vammin, and compared it to the canonical angiogenic factor VEGF-A to evaluate the use of Vammin for therapeutic angiogenesis. Vammin efficiently induced VEGFR-2 mediated proliferation and expression of genes associated with proliferation, migration and angiogenesis. VEGF-A<jats:sub>165<\/jats:sub> and especially VEGF-A<jats:sub>109<\/jats:sub> induced less pronounced effects. Vammin regulates a number of signaling pathways by inducing the expression of NR4A family nuclear receptors and regulators of calcium signaling and MAP kinase pathways. Interestingly, MARC1, which encodes an enzyme discovered to catalyze reduction of nitrate to NO, was identified as a novel VEGFR-2 regulated gene. In rabbit skeletal muscle adenoviral delivery of Vammin induced prominent angiogenic responses. Both the vector dose and the co-receptor binding of the ligand were critical parameters controlling the type of angiogenic response from sprouting angiogenesis to vessel enlargement. Vammin induced VEGFR-2\/NRP-1 mediated signaling more effectively than VEGF-A, consequently it is a promising candidate for development of pro-angiogenic therapies.<\/jats:p>","DOI":"10.1038\/s41598-017-05876-y","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T09:15:05Z","timestamp":1499764505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2\/NRP specific signaling"],"prefix":"10.1038","volume":"7","author":[{"given":"Pyry I.","family":"Toivanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna P.","family":"Laakkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Heikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna U.","family":"Kaikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-2708","authenticated-orcid":false,"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"5876_CR1","doi-asserted-by":"crossref","unstructured":"Yl\u00e4-Herttuala, S., Bridges, C., Katz, M. G. & Korpisalo, P. Angiogenic gene therapy in cardiovascular diseases: dream or vision? Eur. Heart J. 38, 1365\u20131371 (2017).","DOI":"10.1093\/eurheartj\/ehw547"},{"key":"5876_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons, M., Gordon, E. & Claesson-Welsh, L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell Biol. \n                           17, 611\u2013625 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"5876_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1091\/mbc.E09-07-0590","volume":"21","author":"N Ferrara","year":"2010","unstructured":"Ferrara, N. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol. Biol. Cell \n                           21, 687\u201390 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"5876_CR4","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","volume":"269","author":"J Waltenberger","year":"1994","unstructured":"Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. \n                           269, 26988\u201326995 (1994).","journal-title":"J. Biol. Chem."},{"key":"5876_CR5","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","volume":"95","author":"S Hiratsuka","year":"1998","unstructured":"Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA. \n                           95, 9349 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5876_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","volume":"445","author":"M Hellstr\u00f6m","year":"2007","unstructured":"Hellstr\u00f6m, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature \n                           445, 776\u201380 (2007).","journal-title":"Nature"},{"key":"5876_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1083\/jcb.200709114","volume":"181","author":"NC Kappas","year":"2008","unstructured":"Kappas, N. C. et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell Biol. \n                           181, 847\u201358 (2008).","journal-title":"J. Cell Biol."},{"key":"5876_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BJ20071639","volume":"411","author":"C Pellet-Many","year":"2008","unstructured":"Pellet-Many, C., Frankel, P., Jia, H. & Zachary, I. Neuropilins: structure, function and role in disease. Biochem. J. \n                           411, 211\u201326 (2008).","journal-title":"Biochem. J."},{"key":"5876_CR9","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1073\/pnas.022017899","volume":"99","author":"S Takashima","year":"2002","unstructured":"Takashima, S. et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA. \n                           99, 3657\u201362 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5876_CR10","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1182\/blood-2012-05-424713","volume":"121","author":"A Fantin","year":"2013","unstructured":"Fantin, A. et al. NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood \n                           121, 2352\u201362 (2013).","journal-title":"Blood"},{"key":"5876_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/dvdy.20148","volume":"231","author":"H Gerhardt","year":"2004","unstructured":"Gerhardt, H. et al. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. \n                           231, 503\u20139 (2004).","journal-title":"Dev. Dyn."},{"key":"5876_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.str.2015.01.018","volume":"23","author":"MW Parker","year":"2015","unstructured":"Parker, M. W. et al. Structural Basis for VEGF-C Binding to Neuropilin-2 and Sequestration by a Soluble Splice Form. Structure \n                           23, 677\u2013687 (2015).","journal-title":"Structure"},{"key":"5876_CR13","doi-asserted-by":"publisher","first-page":"9885","DOI":"10.1074\/jbc.M809071200","volume":"284","author":"Y Yamazaki","year":"2009","unstructured":"Yamazaki, Y. et al. Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species. J. Biol. Chem. \n                           284, 9885\u201391 (2009).","journal-title":"J. Biol. Chem."},{"key":"5876_CR14","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1074\/jbc.M411395200","volume":"280","author":"K Suto","year":"2005","unstructured":"Suto, K., Yamazaki, Y., Morita, T. & Mizuno, H. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J. Biol. Chem. \n                           280, 2126\u201331 (2005).","journal-title":"J. Biol. Chem."},{"key":"5876_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2008.12.129","volume":"379","author":"Y Matsunaga","year":"2009","unstructured":"Matsunaga, Y., Yamazaki, Y., Suzuki, H. & Morita, T. VEGF-A and VEGF-F evoke distinct changes in vascular ultrastructure. Biochem. Biophys. Res. Commun. \n                           379, 872\u20135 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5876_CR16","doi-asserted-by":"publisher","first-page":"51985","DOI":"10.1074\/jbc.C300454200","volume":"278","author":"Y Yamazaki","year":"2003","unstructured":"Yamazaki, Y., Takani, K., Atoda, H. & Morita, T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J. Biol. Chem. \n                           278, 51985\u201351988 (2003).","journal-title":"J. Biol. Chem."},{"key":"5876_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbagen.2013.10.005","volume":"1840","author":"T Nieminen","year":"2014","unstructured":"Nieminen, T. et al. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Biochim. Biophys. Acta \n                           1840, 454\u201363 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"5876_CR18","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1074\/jbc.M111.331140","volume":"287","author":"MW Parker","year":"2012","unstructured":"Parker, M. W., Xu, P., Li, X. & Vander Kooi, C. W. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J. Biol. Chem. \n                           287, 11082\u20139 (2012).","journal-title":"J. Biol. Chem."},{"key":"5876_CR19","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1073\/pnas.0700043104","volume":"104","author":"CW Vander Kooi","year":"2007","unstructured":"Vander Kooi, C. W. et al. Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl. Acad. Sci. USA. \n                           104, 6152\u20137 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5876_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcmg.2007.10.009","volume":"1","author":"TT Rissanen","year":"2008","unstructured":"Rissanen, T. T. et al. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis. JACC. Cardiovasc. Imaging \n                           1, 83\u201391 (2008).","journal-title":"JACC. Cardiovasc. Imaging"},{"key":"5876_CR21","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/01.ATV.0000098644.03153.6F","volume":"23","author":"D Liu","year":"2003","unstructured":"Liu, D., Jia, H., Holmes, D. I. R., Stannard, A. & Zachary, I. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol. \n                           23, 2002\u20137 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"5876_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/nm.3669","volume":"20","author":"J-S Joyal","year":"2014","unstructured":"Joyal, J.-S. et al. Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis. Nat. Med \n                           20, 1165\u201373 (2014).","journal-title":"Nat. Med"},{"key":"5876_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/dvdy.23753","volume":"241","author":"E Wallgard","year":"2012","unstructured":"Wallgard, E. et al. Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development. Dev. Dyn. \n                           241, 770\u201386 (2012).","journal-title":"Dev. Dyn."},{"key":"5876_CR24","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1523\/JNEUROSCI.3207-05.2005","volume":"25","author":"JD Dougherty","year":"2005","unstructured":"Dougherty, J. D. et al. PBK\/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J. Neurosci. \n                           25, 10773\u201385 (2005).","journal-title":"J. Neurosci."},{"key":"5876_CR25","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1074\/jbc.M114.555177","volume":"289","author":"CE Sparacino-Watkins","year":"2014","unstructured":"Sparacino-Watkins, C. E. et al. Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2. J. Biol. Chem. \n                           289, 10345\u201358 (2014).","journal-title":"J. Biol. Chem."},{"key":"5876_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cellsig.2007.11.009","volume":"20","author":"DIR Holmes","year":"2008","unstructured":"Holmes, D. I. R. & Zachary, I. C. Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. Cell. Signal. \n                           20, 569\u201379 (2008).","journal-title":"Cell. Signal."},{"key":"5876_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood-2004-01-0273","volume":"104","author":"BA Hesser","year":"2004","unstructured":"Hesser, B. A. et al. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood \n                           104, 149\u201358 (2004).","journal-title":"Blood"},{"key":"5876_CR28","doi-asserted-by":"publisher","first-page":"16157","DOI":"10.1073\/pnas.0908201106","volume":"106","author":"T Teesalu","year":"2009","unstructured":"Teesalu, T., Sugahara, K. N., Kotamraju, V. R. & Ruoslahti, E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc. Natl. Acad. Sci. USA. \n                           106, 16157\u201316162 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5876_CR29","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.peptides.2007.09.013","volume":"28","author":"A Starzec","year":"2007","unstructured":"Starzec, A. et al. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR\/neuropilin-1 complex. Peptides \n                           28, 2397\u20132402 (2007).","journal-title":"Peptides"},{"key":"5876_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000354169","volume":"99","author":"I Zachary","year":"2014","unstructured":"Zachary, I. Neuropilins: role in signalling, angiogenesis and disease. Chem. Immunol. Allergy \n                           99, 37\u201370 (2014).","journal-title":"Chem. Immunol. Allergy"},{"key":"5876_CR31","first-page":"ra52","volume":"6","author":"A Anisimov","year":"2013","unstructured":"Anisimov, A. et al. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Sci. Signal. \n                           6, ra52 (2013).","journal-title":"Signal."},{"key":"5876_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0006-291X(02)03033-4","volume":"301","author":"A Kiba","year":"2003","unstructured":"Kiba, A., Sagara, H., Hara, T. & Shibuya, M. VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem. Biophys. Res. Commun. \n                           301, 371\u20137 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5876_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1172\/JCI18420","volume":"113","author":"CR Ozawa","year":"2004","unstructured":"Ozawa, C. R. et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. \n                           113, 516\u201327 (2004).","journal-title":"J. Clin. Invest."},{"key":"5876_CR34","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/eurheartj\/ehq433","volume":"32","author":"P Korpisalo","year":"2011","unstructured":"Korpisalo, P. et al. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy. Eur. Heart J \n                           32, 1664\u20131672 (2011).","journal-title":"Eur. Heart J"},{"key":"5876_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ncb2926","volume":"16","author":"K Bentley","year":"2014","unstructured":"Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. \n                           16, 309\u201321 (2014).","journal-title":"Nat. Cell Biol."},{"key":"5876_CR36","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1101\/gad.242002","volume":"16","author":"C Ruhrberg","year":"2002","unstructured":"Ruhrberg, C. et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev \n                           16, 2684\u201398 (2002).","journal-title":"Genes Dev"},{"key":"5876_CR37","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1182\/blood-2007-12-125856","volume":"112","author":"H Kawamura","year":"2008","unstructured":"Kawamura, H. et al. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood \n                           112, 3638\u201349 (2008).","journal-title":"Blood"},{"key":"5876_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1247663","volume":"343","author":"MM Martino","year":"2014","unstructured":"Martino, M. M. et al. Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing. Science (80\u2212) \n                           343, 885\u2013888 (2014).","journal-title":"Science (80\u2212)"},{"key":"5876_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald, M. et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell \n                           124, 175\u2013189 (2006).","journal-title":"Cell"},{"key":"5876_CR40","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.108.182287","volume":"103","author":"P Korpisalo","year":"2008","unstructured":"Korpisalo, P. et al. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic ves. Circ. Res. \n                           103, 1092\u20139 (2008).","journal-title":"Circ. Res."},{"key":"5876_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genov\u00e9, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell \n                           21, 193\u2013215 (2011).","journal-title":"Dev. Cell"},{"key":"5876_CR42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen, T. T. et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res \n                           92, 1098\u20131106 (2003).","journal-title":"Circ. Res"},{"key":"5876_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen, M. G. et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. \n                           95, 548\u201353 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5876_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature10006","volume":"474","author":"D Wang","year":"2011","unstructured":"Wang, D. et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature \n                           474, 390\u20134 (2011).","journal-title":"Nature"},{"key":"5876_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell \n                           38, 576\u201389 (2010).","journal-title":"Mol. Cell"},{"key":"5876_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics \n                           26, 139\u201340 (2010).","journal-title":"Bioinformatics"},{"key":"5876_CR47","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"MJL DeHoon","year":"2004","unstructured":"DeHoon, M. J. L., Imoto, S., Nolan, J. & Miyano, S. Open source clustering software. Bioinformatics \n                           20, 1453\u20134 (2004).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05876-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05876-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:47:03Z","timestamp":1671778023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05876-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5876"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05876-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"assertion":[{"value":"1 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5525"}}